跳至主要内容
临床试验/CTRI/2024/04/065564
CTRI/2024/04/065564尚未招募3 期

Effectiveness of non hormonal treatment for the management of obese PCOS patients compared to the standard treatment.

PGIMER post graduate institute of medical education and research1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2025年3月12日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
54
试验地点
1
主要终点
percentage reduction in body weight

研究概览

简要总结

this trial is aimed for treating PCOS patients targeting the pathophysiology of disease and not just providing symptomatic treatment.here we have taken 3 arms of intervention. arm1 is intensive lifestyle modification along with metformin and anti androgens. arm 2 is semaglutide , metformin and anti androgens and arm 3 is oral contraceptive pills with spironolactone. we will be assessing reduction in body weight and free androgen index reduction as primary objectives.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • 3 arms are there for PCOS treatment.
  • arm 1 being given drugs with lifestyle modification , arm 2 being given only drugs and arm 3 being given standard treatment with OCPs.

排除标准

  • age less than 18 years and more than 40 years female type 2 DM malignancy acute infection chronic infection pregnant.

结局指标

主要结局

percentage reduction in body weight

时间窗: at 12 months

free androgen index

时间窗: at 12 months

次要结局

  • menstrual irregularities(hirsutism)

研究者

发起方
PGIMER post graduate institute of medical education and research
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Rama Walia

PGIMER ( post graduate institute of medical education and research )

研究点 (1)

Loading locations...

相似试验